Gracell Biotechnologies Inc ADR (GRCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GRCL | AZN | AMGN | GILD | BMY |
| Company | Gracell Biotechnologies Inc ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 10.26 | 170.83 | 379.50 | 129.90 | 62.39 |
| High | 10.28 | 170.83 | 379.50 | 129.90 | 62.39 |
| Low | 10.17 | 170.83 | 379.50 | 129.90 | 62.39 |
| Latest | 10.25 | 170.83 | 379.50 | 129.90 | 62.39 |
| Change | +0.01 | +1.57 | +3.46 | +0.59 | +0.30 |
| % Change | +0.05% | +0.93% | +0.92% | +0.46% | +0.48% |
| Volume | 6,417,100 | 53,292 | 2,125 | 1,892 | 8,390 |
| 20-Day Average Volume | 1,332,340 | 2,592,160 | 2,107,266 | 6,396,760 | 9,800,330 |
| Previous Close | 10.25 | 169.26 | 376.04 | 129.31 | 62.09 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.21 | 176.74 | 366.15 | 131.20 | 59.13 |
| 20-Day Raw Stochastic | 53.16% | 20.93% | 100.00% | 34.77% | 93.40% |
| 20-Day Relative Strength | 72.75 | 44.14 | 63.32 | 49.06 | 61.42 |
| Weighted Alpha | +228.20 | +5.73 | +28.90 | +10.32 | +39.34 |
| Today's Opinion | 100% Buy | 88% Sell | 100% Buy | 40% Sell | 72% Buy |
| Previous Opinion | 100% Buy | 88% Sell | 88% Buy | 56% Sell | 72% Buy |
| Last Month's Opinion | 100% Buy | 24% Sell | 56% Buy | 72% Sell | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.87% since 02/13/24 | +3.84% since 07/20/26 | +4.21% since 07/20/26 | -2.48% since 07/20/26 | +3.71% since 07/20/26 |
| Low | 10.09 on 02/16/24 | 164.82 on 07/21/26 | 359.21 on 07/23/26 | 127.61 on 07/23/26 | 59.80 on 07/21/26 |
| High | 10.35 on 02/14/24 | 170.89 on 07/22/26 | 379.50 on 07/27/26 | 132.87 on 07/21/26 | 62.82 on 07/24/26 |
| 1-Month | |||||
| %Chg | +2.60% since 01/19/24 | -9.33% since 06/26/26 | +5.91% since 06/26/26 | +1.58% since 06/26/26 | +8.47% since 06/26/26 |
| Low | 9.97 on 01/22/24 | 164.06 on 07/20/26 | 353.95 on 07/15/26 | 124.19 on 06/30/26 | 56.30 on 07/01/26 |
| High | 10.44 on 02/09/24 | 196.41 on 07/02/26 | 379.50 on 07/27/26 | 140.61 on 07/17/26 | 62.82 on 07/24/26 |
| 3-Month | |||||
| %Chg | +109.61% since 11/21/23 | -8.90% since 04/27/26 | +11.56% since 04/27/26 | +1.68% since 04/27/26 | +7.98% since 04/27/26 |
| Low | 3.80 on 11/28/23 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 10.44 on 02/09/24 | 196.41 on 07/02/26 | 379.50 on 07/27/26 | 140.61 on 07/17/26 | 62.82 on 07/24/26 |
| 6-Month | |||||
| %Chg | +222.33% since 08/21/23 | -10.65% since 01/27/26 | +8.02% since 01/27/26 | -7.85% since 01/27/26 | +12.29% since 01/27/26 |
| Low | 2.10 on 10/04/23 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 10.44 on 02/09/24 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 744,950 | 262,506,688 | 202,951,808 | 160,547,408 | 126,792,192 |
| Shares Outstanding, K | 72,678 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -88,080,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -9,270,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | -0.33 | 0.24 | 0.41 | 0.32 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 11/13/23 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 03/11/24 | 07/27/26 | 08/04/26 | 08/04/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.17 | 16.81 | 15.63 | 10.37 |